A Prospective, Multicenter Registry With Targeted Temperature Management After Out-of-hospital Cardiac Arrest in Korea

October 19, 2016 updated by: Kyu Nam Park
Therapeutic hypothermia after out-of-hospital cardiac arrest is considered as a standard care. However, optimal candidates, optimal dose, duration, timing of initiation and rate of rewarming is still unknown. The objective of this project is to improve the outcomes for patients after resuscitation from out-of-hospital cardiac arrest treated with therapeutic hypothermia established from the analysis of multicenter registry data.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1800

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Seoul, Korea, Republic of, 06591
        • Recruiting
        • Seoul St. Mary's Hospital, The Catholic University of Korea
        • Contact:
        • Principal Investigator:
          • Ji Hoon Kim, MD, PhD
        • Principal Investigator:
          • Won Jung Jeong, MD
        • Principal Investigator:
          • Seung Pill Choi, MD, PhD
        • Principal Investigator:
          • Mi Jin Lee, MD, PhD
        • Principal Investigator:
          • Jong-Seok Lee, MD, PhD
        • Principal Investigator:
          • Su Jin Kim, MD, PhD
        • Principal Investigator:
          • Tae Chang Jang, MD, PhD
        • Principal Investigator:
          • Inbyung Kim, MD
        • Principal Investigator:
          • Yong Hwan Kim, MD
        • Principal Investigator:
          • Won Young Kim, MD, PhD
        • Principal Investigator:
          • Jonghwan Jonghwan, MD
        • Principal Investigator:
          • Ji Hwan Lee, MD
        • Principal Investigator:
          • Giwoon Kim, MD
        • Principal Investigator:
          • Wook-jin Choi, MD, PhD
        • Principal Investigator:
          • Joo Suk Oh, MD PhD
        • Principal Investigator:
          • Chul Han, MD, PhD
        • Principal Investigator:
          • Byung Kook Lee, MD, PhD
        • Principal Investigator:
          • Taeoh Jeong, MD, PhD
        • Principal Investigator:
          • Dong Hoon Lee, MD, PhD
        • Principal Investigator:
          • Jin Hong Min, MD
        • Principal Investigator:
          • Gyu Chong Cho, MD, PhD
        • Principal Investigator:
          • Young Hwan Lee, MD
        • Principal Investigator:
          • In Soo Cho, MD
        • Principal Investigator:
          • Je Sung You, MD, PhD
        • Principal Investigator:
          • Changsun Kim, MD. PhD
        • Principal Investigator:
          • Kyoung-Chul Cha, MD
        • Principal Investigator:
          • Soo Hyung Cho, MD. PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

patients treated with therapeutic hypothermia after out-of-hospital cardiac arrest.

Description

Inclusion Criteria:

  • age of older than 18 years
  • out-of-hospital cardiac arrest
  • comatose mentality after return of spontaneous circulation (ROSC)
  • treated with therapeutic hypothermia, regardless of target temperature

Exclusion Criteria:

  • suspected or confirmed to cerebrovascular accident
  • poor pre-arrest neurologic status (CPC>3)
  • patients who are terminally ill or for whom intensive care dose not seem to be appropriate
  • Do not attempt resuscitation (DNAR) order
  • patients with tympanic membrane temperature below 30 degree celsius on admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
survival
Time Frame: 6 months after cardiac arrest
6 months after cardiac arrest
Neurologic Outcome
Time Frame: 6 months after cardiac arrest
Cerebral Performance Category (CPC). CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
6 months after cardiac arrest
Neurologic Outcome
Time Frame: after 6 months
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
after 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
survival
Time Frame: duration of hospitalization, limit 180 days
duration of hospitalization, limit 180 days
neurological outcome
Time Frame: duration of hospitalization, limit 180 days
Cerebral Performance Category (CPC). CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
duration of hospitalization, limit 180 days
neurological outcome
Time Frame: duration of hospitalization, limit 180 days
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
duration of hospitalization, limit 180 days
Survival
Time Frame: 1 month after cardiac arrest
1 month after cardiac arrest
neurological outcome
Time Frame: 1 month after cardiac arrest
Cerebral Performance Category (CPC). CPC 1,2 : Good Outcome CPC 3,4,5 : Poor Outcome
1 month after cardiac arrest
neurological outcome
Time Frame: 1 month after cardiac arrest
modified Rankin Scale (mRS) mRS 0,1,2, 3 : Good Outcome mRS 4,5,6 : Poor Outcome
1 month after cardiac arrest

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Kyu Nam Park, MD. PhD, Seoul St. Mary's Hospital, The Catholic University of Korea

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2015

Primary Completion (Anticipated)

June 1, 2019

Study Completion (Anticipated)

June 1, 2019

Study Registration Dates

First Submitted

July 5, 2016

First Submitted That Met QC Criteria

July 6, 2016

First Posted (Estimate)

July 11, 2016

Study Record Updates

Last Update Posted (Estimate)

October 21, 2016

Last Update Submitted That Met QC Criteria

October 19, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 2015-P33001-00

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Out-of-Hospital Cardiac Arrest

Clinical Trials on not provided

3
Subscribe